Seattle-area microbiome and diagnostics startup Viome Life Sciences is elevating additional cash, based on a brand new regulatory submitting.
The submitting reveals $67 million raised of a bigger spherical. We’ve reached out to Viome to be taught extra and can replace once we hear again. Replace: Viome corroborated the funding quantity in an announcement Tuesday.
Viome sells a equipment to find out the microbial composition of stool samples and recommends “precision” dietary supplements and probiotics primarily based on a person’s readout. This July, the corporate launched a “Full Physique Intelligence Take a look at” that additionally analyzes saliva and blood samples. Earlier this 12 months superstar and socialite Paris Hilton turned a Viome model ambassador.
The corporate can also be growing a diagnostic check for oral and throat most cancers that has acquired breakthrough system designation from the FDA, enabling it to obtain expedited evaluation previous to approval.
In April 2021, the six-year outdated firm stated it had greater than 200,000 clients and was anticipating income to hit $100 million in 2022.
Viome is the seventh enterprise of founder and CEO Naveen Jain. Jain is the founder and former CEO of InfoSpace and in addition co-founded public information agency Intelius, in addition to Moon Specific, which goals to take paying clients to the moon.
Viome raised $54 million raised in November, bringing its complete funding to greater than $125 million.
Viome’s earlier buyers embody Khosla Ventures, WestRiver Group, Glico, Doctor Companions, Ocgrow Ventures and Daring Capital Group. All these buyers participated within the new funding spherical, which was led by Daring Capital. Salesforce CEO Marc Benioff was an early investor within the firm.
Conclusion: So above is the Naveen Jain’s microbiome and diagnostics startup Viome is elevating additional cash article. Hopefully with this article you can help you in life, always follow and read our good articles on the website: Doshared.com